Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 Å resolution

被引:0
|
作者
Michael A. Hanson
Raymond C. Stevens
机构
[1] The Scripps Research Institute,Department of Chemistry and Molecular Biology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Botulinum neurotoxin serotype B is a zinc protease that disrupts neurotransmitter release by cleaving synaptobrevin-II (Sb2), one of three SNARE proteins involved in neuronal synaptic vesicle fusion. The three-dimensional crystal structure of the apo botulinum neurotoxin serotype B catalytic domain (BoNT/B-LC) has been determined to 2.2 Å resolution, and the complex of cleaved Sb2 with the catalytic domain (Sb2–BoNT/B-LC) has been determined to 2.0 Å resolution. A comparison of the holotoxin catalytic domain and the isolated BoNT/B-LC structure shows a rearrangement of three active site loops. This rearrangement exposes the BoNT/B active site. The Sb2–BoNT/B-LC structure illustrates two distinct binding regions, which explains the specificity of each botulinum neurotoxin for its synaptic vesicle protein. This observation provides an explanation for the proposed cooperativity between binding of full-length substrate and catalysis and suggest a mechanism of synaptobrevin proteolysis employed by the clostridial neurotoxins.
引用
收藏
页码:687 / 692
页数:5
相关论文
共 50 条
  • [31] Structural basis for BABIM inhibition of botulinum neurotoxin type B protease
    Hanson, MA
    Oost, TK
    Sukonpan, C
    Rich, DH
    Stevens, RC
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (45) : 11268 - 11269
  • [32] Stimulation of tissue transglutaminase activity by Clostridium botulinum neurotoxin type B
    Moon, YS
    Yang, GH
    Rhee, SD
    Jung, HH
    JOURNAL OF MICROBIOLOGY, 2003, 41 (02) : 161 - 164
  • [33] Comparative endopeptidase activity of Clostridium botulinum Type B Neurotoxin Complex and Recombinant Type B light Chain to explore the role of neurotoxin associated proteins in active enzyme structure
    Riding, S
    Lindo, P
    Biegel, E
    Singh, BR
    FASEB JOURNAL, 2004, 18 (08): : C141 - C141
  • [34] Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA
    Nishiki, T
    Tokuyama, Y
    Kamata, Y
    Nemoto, Y
    Yoshida, A
    Sekiguchi, M
    Takahashi, M
    Kozaki, S
    NEUROSCIENCE LETTERS, 1996, 208 (02) : 105 - 108
  • [35] TYPE-A AND B NEUROTOXIN GENES IN A CLOSTRIDIUM-BOTULINUM TYPE AB STRAIN
    FUJINAGA, Y
    TAKESHI, K
    INOUE, K
    FUJITA, R
    OHYAMA, T
    MORIISHI, K
    OGUMA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (03) : 737 - 745
  • [36] REDUCTIVE METHYLATION OF LYSINE RESIDUES OF BOTULINUM NEUROTOXIN TYPE-A AND TYPE-B
    SATHYAMOORTHY, V
    DASGUPTA, BR
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1988, 83 (01) : 65 - 72
  • [37] Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II
    Zhou, Y
    Foss, S
    Lindo, P
    Sarkar, H
    Singh, BR
    FEBS JOURNAL, 2005, 272 (11) : 2717 - 2726
  • [38] Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling
    Kumar, Gyanendra
    Kumaran, Desigan
    Ahmed, S. Ashraf
    Swaminathan, Subramanyam
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2012, 68 : 511 - 520
  • [39] BLOCKADE BY BOTULINUM NEUROTOXIN-B OF CATECHOLAMINE RELEASE FROM ADRENOCHROMAFFIN CELLS CORRELATES WITH ITS CLEAVAGE OF SYNAPTOBREVIN AND A HOMOLOG PRESENT ON THE GRANULES
    FORAN, P
    LAWRENCE, G
    DOLLY, JO
    BIOCHEMISTRY, 1995, 34 (16) : 5494 - 5503
  • [40] Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin
    Matsumura, Takuhiro
    Kitamura, Mayu
    Amatsu, Sho
    Yamaguchi, Aki
    Kobayashi, Nobuhide
    Yutani, Masahiro
    Fujinaga, Yukako
    MICROBIOLOGY AND IMMUNOLOGY, 2024, 68 (10) : 348 - 358